Immunotherapy in microsatellite stable colorectal cancer. Current evidence and surgical perspectives
Hellenic Journal of Surgery · 23.07.2026 · 95 (2) · 68-77
DOI: 10.59869/25063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hellenic Journal of Surgery, online erschienen am 23.07.2026. Verfasst von Savvas Tsaramanidis und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) represents one of the most frequent malignancies worldwide and one of the leading causes of cancer-related mortality. Over the years the treatment options include radiotherapy, chemotherapy and surgery. Immune checkpoint inhibitors (ICIs) show favorable efficacy in microsatellite instability (MSI-H) CRC, however there is no clear benefit in microsatellite-stable tumors (MSS). Since only around 15% of colorectal cancers are MSI-H and the remaining 85% are MSS, the limited efficacy of ICIs in MSS tumors remains a therapeutic challenge. This narrative review aims to examine the mechanisms of therapeutic resistance to ICIs in MSS CRC overall, to summarize the available clinical evidence, and to discuss possible strategies to enhance immunotherapy efficacy. Attention is also given to the evolving role of surgery within modern multifactor management including the potential interaction of immunotherapy across resectable, borderline resectable and metastatic disease settings.
Methods
A narrative review was conducted using Pubmed, Scopus and Web of Science databases. The literature search included articles published up to May 2026. The following keywords were used: “microsatellite stable”, “colorectal cancer”, “immune checkpoint inhibitors”, “immunotherapy” and “colectomy”. Narrative reviews, retrospective studies, and systematic reviews in English were considered eligible for inclusion.
Results
MSS CRC is characterized by chromosomal instability involving large-scale genomic alterations and is associated with a low tumor mutational burden (ΤΜΒ) and limited neoantigen formation, contributing to the limited efficacy of ICIs. Many molecular pathways are responsible for this condition such as Wnt/β-catenin pathway, Mitogen-Activated Protein Kinase (MAPK) pathway and the transforming growth factor-β (TGF-β) pathway. Some trials (IMblaze370, KEYNOTE-016) highlight the limited efficacy of ICIs as monotherapy in MSS CRC and investigate the combined treatments to overcome the resistance. Surgery remains the cornerstone of CRC treatment; however, a non-operative (watch-and-wait) approach may be safe alternative to surgery in selected patients with MSS CRC.
Conclusions
ICIs have changed the management of MSI-H CRC but remain ineffective as monotherapy in MSS CRC. Combination treatments targeting the tumor microenvironment, angiogenesis and oncogenic signaling pathways represent promising direction for improving immunotherapy efficacy. In this context, surgery continues to play a central role in the management of colorectal cancer. Patients with resectable disease, locally advanced and selected cases of metastatic diseases may benefit from this multidisciplinary approach. Beyond its established cytoreductive effect, surgical intervention may help modify the tumor microenvironment and reduce systemic immunosuppressive signaling. Surgery may also improve the responsiveness to immunotherapy. Future studies are needed to better define patient selection, optimal treatment choice and the role of multidisciplinary teams in the decision between systemic and locoregional therapies.
Zitieren
APA
Tsaramanidis, S., Skriapa, A., Sarigiannidis, I., Boukovinas, I., Zacharioudakis, G., & Ballas, K. (2026). Immunotherapy in microsatellite stable colorectal cancer. Current evidence and surgical perspectives. Hellenic Journal of Surgery, 95(2), 68-77. https://doi.org/10.59869/25063
Vancouver
Tsaramanidis S, Skriapa A, Sarigiannidis I, Boukovinas I, Zacharioudakis G, Ballas K. Immunotherapy in microsatellite stable colorectal cancer. Current evidence and surgical perspectives. Hellenic Journal of Surgery. 2026;95(2):68-77. doi:10.59869/25063
BibTeX
@article{Tsaramanidis2026,
author = {Tsaramanidis, Savvas and Skriapa, Athina and Sarigiannidis, Ilias and Boukovinas, Ioannis and Zacharioudakis, Georgios and Ballas, Konstantinos},
title = {Immunotherapy in microsatellite stable colorectal cancer. Current evidence and surgical perspectives},
journal = {Hellenic Journal of Surgery},
year = {2026},
volume = {95},
number = {2},
pages = {68--77},
doi = {10.59869/25063}
}
EUVIMED